SLC2A1 and renal carcinoma: Downregulation of miR-1291 in renal cancer, miR-195-5p in bladder cancer, and miR-150 in pancreatic cancer leads to enhanced expression of their direct targets, GLUT1, GLUT3, and GLUT4 respectively, which thus results in glucose uptake and contributes to tumor progression58–60.